Assignee
WUXI BIOCITY BIOPHARMACEUTICS CO LTD
CN·6 granted patents·4 citations·filing 2018–2020
Top patents by PatentIndex Score
6 records- 0181US11434232B2ATR inhibitor and application thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2019·Granted Sep 6, 2022·2 cites·19 claims
- 0280US11613545B2Macrocyclic compound serving as Wee1 inhibitor and applications thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2018·Granted Mar 28, 2023·2 cites·20 claims
- 0348US12479839B2Crystalline form of ATR inhibitor and use thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2020·Granted Nov 25, 2025·0 cites·20 claims
- 0445US12180184B2Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2019·Granted Dec 31, 2024·0 cites·22 claims
- 0544US12291536B2Crystal form of Wee1 inhibitor compound and use thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2020·Granted May 6, 2025·0 cites·28 claims
- 0643US12297192B2Crystal form of pyrimidine sulfonamide compound and preparation method thereforWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2020·Granted May 13, 2025·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when WUXI BIOCITY BIOPHARMACEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →